Zacks: Brokerages Set $6.00 Price Target for Digirad Co. (DRAD)
Shares of Digirad Co. (NASDAQ:DRAD) have been assigned a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that cover the stock, Zacks Investment Research reports. One analyst has rated the stock with a strong buy recommendation.
Brokerages have set a 1 year consensus price objective of $6.00 for the company, according to Zacks. Zacks has also assigned Digirad an industry rank of 209 out of 265 based on the ratings given to related companies.
Several equities analysts recently issued reports on the stock. B. Riley reissued a “buy” rating and set a $6.00 price objective on shares of Digirad in a research note on Thursday, October 5th. TheStreet downgraded shares of Digirad from a “c” rating to a “d+” rating in a research note on Friday, November 3rd.
Digirad (NASDAQ:DRAD) opened at $2.37 on Friday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.07 and a current ratio of 1.44. The stock has a market cap of $48.13, a P/E ratio of 8.28 and a beta of 1.89. Digirad has a one year low of $1.90 and a one year high of $5.68.
Digirad (NASDAQ:DRAD) last announced its quarterly earnings data on Friday, November 3rd. The medical equipment provider reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.04. The business had revenue of $28.56 million for the quarter, compared to the consensus estimate of $31.21 million. Digirad had a negative net margin of 9.93% and a positive return on equity of 9.82%. research analysts forecast that Digirad will post 0.09 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Thursday, November 30th. Investors of record on Monday, November 20th were given a dividend of $0.055 per share. This represents a $0.22 annualized dividend and a yield of 9.28%. The ex-dividend date of this dividend was Friday, November 17th. Digirad’s dividend payout ratio (DPR) is -37.93%.
Digirad Company Profile
Digirad Corporation provides healthcare solutions. The Company’s segments include Diagnostic Services, Mobile Healthcare, Diagnostic Imaging and Medical Device Sales and Services. Through Diagnostic Services, the Company offers an imaging services program as an alternative to purchasing equipment or outsourcing the procedures to another physician or imaging center.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Digirad Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad Co. and related companies with MarketBeat.com's FREE daily email newsletter.